{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:32:23Z","timestamp":1791837143921,"version":"4.3.4"},"reference-count":127,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Myeloid sarcoma (MS), an extramedullary form of acute myeloid leukemia (AML) is a rare tumor mass of myeloid blasts. It can disseminate to any one or multiple anatomical sites, with (synchronous MS) or without (isolated MS) bone marrow (BM) involvement. The aim of this review is to describe the most recent advances in MS regarding diagnosis, molecular background, various clinical manifestations from several organs, and treatment approaches. Due to the lack of prospective, randomized clinical trials, therapeutic decisions are a challenge for the clinician. In the era of novel targeted AML treatments, a critical analysis of how to decide the best option for individual patients, also covering the possible central nervous system (CNS) prophylaxis is provided. For the majority of the patients, AML induction chemotherapy, followed by hematopoietic stem cell transplantation (HSCT) is generally recommended. This paper discusses the role of radiotherapy, the treatment of refractory and relapsed disease, along with the therapeutic approach of difficult-to-treat patients, due to specific problems related to different anatomical sites of MS.<\/jats:p>","DOI":"10.3390\/jcm13206154","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T07:58:32Z","timestamp":1729065512000},"page":"6154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Myeloid Sarcoma: Novel Advances Regarding Molecular Pathogenesis, Presentation and Therapeutic Options"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-5930","authenticated-orcid":false,"given":"Michael D.","family":"Diamantidis","sequence":"first","affiliation":[{"name":"Thalassemia and Sickle Cell Disease Unit, Department of Hematology, 1st Department of Internal Medicine, General Hospital of Larissa, Tsakalov Str. 1, 41 221 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.semdp.2023.04.009","article-title":"Myeloid sarcoma: An overview","volume":"40","author":"Chen","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00277-023-05288-1","article-title":"Myeloid sarcoma: More and less than a distinct entity","volume":"102","author":"Loscocco","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000497210","article-title":"Myeloid Sarcoma","volume":"42","author":"Magdy","year":"2019","journal-title":"Oncol. Res. Treat."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2020","journal-title":"Blood Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1751-553X.2011.01361.x","article-title":"State of the art in myeloid sarcoma","volume":"33","author":"Klco","year":"2011","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: Extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid Sarcoma: Presentation, Diagnosis, and Treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980\u20132008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: Analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/10428194.2014.963080","article-title":"Presentation and outcomes among patients with isolated myeloid sarcoma: A Surveillance, Epidemiology, and End Results database analysis","volume":"56","author":"Movassaghian","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOH.0000000000000571","article-title":"Myeloid sarcoma","volume":"27","author":"Shahin","year":"2020","journal-title":"Curr. Opin. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00277-011-1378-x","article-title":"Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma","volume":"91","author":"Kaiafa","year":"2012","journal-title":"Ann. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00432-020-03128-7","article-title":"Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia","volume":"146","author":"Xu","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_21","first-page":"989","article-title":"Myeloid sarcoma: A clinicopathological study with emphasis on diagnostic difficulties","volume":"13","author":"Kudva","year":"2017","journal-title":"J. Cancer Res. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2478\/raon-2019-0014","article-title":"Radiological and clinical patterns of myeloid sarcoma","volume":"53","author":"Meyer","year":"2019","journal-title":"Radiol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1080\/10428194.2016.1225208","article-title":"Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing","volume":"58","author":"Pastoret","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.5858\/arpa.2012-0537-OA","article-title":"Myeloid sarcoma of the head and neck region","volume":"137","author":"Zhou","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s12328-021-01438-y","article-title":"An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: A case report and review of literature","volume":"14","author":"Matsunaga","year":"2021","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5414\/NP301473","article-title":"Primary central nervous system histiocytic sarcoma with somatic NF2 mutation: Case report and review of literature","volume":"41","author":"Wang","year":"2022","journal-title":"Clin. Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2141.1988.tb02397.x","article-title":"Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: A histological and immunohistological study","volume":"69","author":"Horny","year":"1988","journal-title":"Br. J. Haematol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhao, H., Dong, Z., Wan, D., Cao, W., Xing, H., Liu, Z., Fan, J., Wang, H., Lu, R., and Zhang, Y. (2022). Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-10831-7"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anndiagpath.2014.06.001","article-title":"A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia","volume":"18","author":"Seifert","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11864-023-01063-6","article-title":"Gene Mutations and Targeted Therapies of Myeloid Sarcoma","volume":"24","author":"Fu","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ejh.13056","article-title":"Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study","volume":"100","author":"Claerhout","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_32","first-page":"333","article-title":"Myeloid Sarcoma with CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen","volume":"153","author":"Dalland","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_33","first-page":"8178","article-title":"T cell acute lymphoblastic lymphoma complicated with myeloid sarcoma in an adult: A case report","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: A single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.clml.2018.03.013","article-title":"Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?","volume":"18","author":"Pramanik","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-021-04702-w","article-title":"Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy","volume":"101","author":"Shallis","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10428194.2017.1339879","article-title":"Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing","volume":"59","author":"Kashofer","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1080\/10428194.2019.1571199","article-title":"A complex mutational profile and a distinct clonal evolution during NPM1 myeloid sarcoma","volume":"60","author":"Fouillet","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/leu.2015.81","article-title":"Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma","volume":"29","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wang, J., Ye, X., Fan, C., Zhou, J., Luo, S., Jin, J., Chen, D., Zheng, Y., Wu, C., and Zhu, X. (2020). Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML. Biomark. Res., 8.","DOI":"10.1186\/s40364-020-00246-9"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival","volume":"22","author":"Werstein","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00277-014-2082-4","article-title":"Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis","volume":"93","author":"Granada","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pbc.22500","article-title":"Chemokine\/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7","volume":"55","author":"Faaij","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2141.2007.06590.x","article-title":"The CXCR4 chemokine receptor in acute and chronic leukaemia: A marrow homing receptor and potential therapeutic target","volume":"137","author":"Burger","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.2022017046","article-title":"C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse","volume":"141","author":"Yang","year":"2023","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hon.2782","article-title":"MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma","volume":"38","author":"Sapienza","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1080\/10428194.2021.1961235","article-title":"Clinical and molecular characterization of myeloid sarcoma without medullary leukemia","volume":"62","author":"Abbas","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/pde.13824","article-title":"Disseminated De Novo Myeloid Sarcoma in a 17-year-old Boy","volume":"36","author":"Sandre","year":"2019","journal-title":"Pediatr. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12185-014-1659-y","article-title":"Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: A single institution experience","volume":"100","author":"Peker","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.clml.2019.04.013","article-title":"Testicular Myeloid Sarcoma: A Systematic Review of the Literature","volume":"19","author":"Sahu","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mpo.10069","article-title":"Isolated extramedullary relapse in acute myeloid leukemia: A retrospective analysis","volume":"38","author":"Ginsberg","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13000-019-0892-3","article-title":"Vulvar myeloid sarcoma as the presenting symptom of acute myeloid leukemia: A case report and literature review of Chinese patients, 1999\u20132018","volume":"14","author":"Zhang","year":"2019","journal-title":"Diagn. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13000-019-0804-6","article-title":"Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass","volume":"14","author":"Bao","year":"2019","journal-title":"Diagn. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"612","DOI":"10.12659\/AJCR.915453","article-title":"Sonographic Features of a Myeloid Sarcoma of the Breast as a Relapse of Acute Myeloid Leukemia after Stem-Cell Transplantation: A Case Report","volume":"20","author":"Kim","year":"2019","journal-title":"Am. J. Case Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00277-013-1850-x","article-title":"MLL-AF9 rearrangement in myeloid sarcomas involving the breast","volume":"93","author":"Wu","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00277-003-0668-3","article-title":"Primary extramedullary myeloid tumor of the breast: A case report and review of the literature","volume":"82","author":"Fraga","year":"2003","journal-title":"Ann. Hematol."},{"key":"ref_58","first-page":"xe01","article-title":"Cardiac Myeloid Sarcoma: Review of Literature","volume":"11","author":"Gautam","year":"2017","journal-title":"J. Clin. Diagn. Res. JCDR"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.joms.2009.09.040","article-title":"Intraoral granulocytic sarcoma: A case report and review of the literature","volume":"68","author":"Pau","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/cco-19-250","article-title":"Review on gall bladder myeloid sarcoma: A great masquerader","volume":"9","author":"Sahu","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4103\/IJPM.IJPM_371_18","article-title":"Myeloid sarcoma of bile ducts presenting as obstructive jaundice\u2014A case report","volume":"62","author":"Agarwal","year":"2019","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3748\/wjg.v17.i4.540","article-title":"Isolated pancreatic granulocytic sarcoma: A case report and review of the literature","volume":"17","author":"Li","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000074223","article-title":"Granulocytic sarcoma of the pancreas. A report of one case and review of the literature","volume":"110","author":"Caldera","year":"2003","journal-title":"Acta Haematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7819-10-13","article-title":"Isolated granulocytic sarcoma of the pancreas: A tricky diagnostic for primary pancreatic extramedullary acute myeloid leukemia","volume":"10","author":"Messager","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"ref_65","first-page":"e8462","article-title":"Pancreatic Myeloid Sarcoma","volume":"12","author":"Parker","year":"2020","journal-title":"Cureus"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e7934","DOI":"10.1097\/MD.0000000000007934","article-title":"A myeloid sarcoma involving the small intestine, kidneys, mesentery, and mesenteric lymph nodes: A case report and literature review","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ying, L., Tian, L., Xie, Y., Wang, Q., Che, X., Yan, J., Shen, L., Huang, H., Chen, F., and Zhang, M. (2018). A case of ureteral myeloid sarcoma post-renal transplantation. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-0838-0"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.3892\/ol.2016.4517","article-title":"Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature","volume":"11","author":"Yu","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/j.leukres.2010.09.006","article-title":"Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy","volume":"34","author":"Firat","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_71","first-page":"941","article-title":"Myeloid sarcoma and adenocarcinoma of the large bowel as collision tumors: A case report","volume":"27","author":"Rocca","year":"2012","journal-title":"Histol. Histopathol."},{"key":"ref_72","first-page":"4158","article-title":"A primary myeloid sarcoma involving the small intestine and mesentery: Case report and literature review","volume":"11","author":"He","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_73","first-page":"222","article-title":"A rare case of myeloid sarcoma presenting as anal fissure","volume":"36","author":"Vecchio","year":"2015","journal-title":"G. Chir."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"763","DOI":"10.12659\/AJCR.910434","article-title":"Peritoneal Myeloid Sarcoma in a Patient Treated for a Testicular Seminoma","volume":"19","author":"Longo","year":"2018","journal-title":"Am. J. Case Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.2020004975","article-title":"Placental myeloid sarcoma","volume":"135","author":"Marra","year":"2020","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13312-014-0332-0","article-title":"Granulocytic sarcoma of the lung in acute myeloid leukemia","volume":"51","author":"Thawani","year":"2014","journal-title":"Indian Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000488057","article-title":"Myeloid Sarcoma with Megakaryoblastic Differentiation Arising in the Conjunctiva","volume":"5","author":"Jakobiec","year":"2019","journal-title":"Ocul. Oncol. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"bcr-2018","DOI":"10.1136\/bcr-2018-226284","article-title":"Myeloid sarcoma presenting as an unusual limbal mass","volume":"12","author":"Meel","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/jamaophthalmol.2020.0110","article-title":"An Iridociliochoroidal Myeloid Sarcoma Associated with Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation, Treated with Gilteritinib, an FLT3 Inhibitor","volume":"138","author":"Kim","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijporl.2019.04.002","article-title":"Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia","volume":"122","author":"Chen","year":"2019","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/OTT.S230478","article-title":"Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma","volume":"13","author":"Zhou","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.abd.2019.09.001","article-title":"Myeloid sarcoma on the scalp of a patient with acute myeloid leukemia","volume":"94","author":"Muniz","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12185-023-03656-1","article-title":"Myeloid sarcoma and pathological fracture: A case report and review of literature","volume":"118","author":"Takeyasu","year":"2023","journal-title":"Int. J. Hematol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cup.12231","article-title":"Aleukemic cutaneous myeloid sarcoma","volume":"40","author":"Aboutalebi","year":"2013","journal-title":"J. Cutan. Pathol."},{"key":"ref_85","first-page":"321289","article-title":"Granulocytic Sarcoma of Parotid Gland in a 4-Year-Old Child with Subleukemic AML: A Diagnostic Challenge!","volume":"2013","author":"Ingale","year":"2013","journal-title":"Case Rep. Otolaryngol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.oooo.2017.11.013","article-title":"Multifocal occurrence of intraoral isolated MS in a patient without leukemic presentation: A case report and literature review","volume":"125","author":"Shen","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12185-014-1508-z","article-title":"Concurrent presentation of nodal myeloid sarcoma and bone marrow chronic lymphocytic leukemia\/small lymphocytic lymphoma: A unique association","volume":"99","author":"Perifanis","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_88","first-page":"120","article-title":"Concomitant myeloid sarcoma and plasma cell myeloma--case report of a hitherto undescribed association of two neoplasms","volume":"23","author":"Rudzki","year":"2007","journal-title":"Pol. Merkur. Lek."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0972-3919.198478","article-title":"Mixed Phenotypic Acute Leukemia (mixed myeloid\/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation-Detected on FDG PET\/CT","volume":"32","author":"Khanna","year":"2017","journal-title":"Indian J. Nucl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10238-020-00616-5","article-title":"Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: A case report and review of the literature","volume":"20","author":"Coltro","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/abd1806-4841.20176042","article-title":"Cutaneous myeloid sarcoma associated with chronic myeloid leukemia","volume":"92","author":"Vasconcelos","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"bcr2014207466","DOI":"10.1136\/bcr-2014-207466","article-title":"Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remission","volume":"2014","author":"Kittai","year":"2014","journal-title":"BMJ Case Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","article-title":"Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Tallman","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijrobp.2018.05.045","article-title":"Use of Radiation in Extramedullary Leukemia\/Chloroma: Guidelines from the International Lymphoma Radiation Oncology Group","volume":"102","author":"Bakst","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1748-717X-8-245","article-title":"Clinicopathologic features and responses to radiotherapy of myeloid sarcoma","volume":"8","author":"Chen","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-012-1540-0","article-title":"Isolated central nervous system relapse presenting as myeloid sarcoma of acute myeloid leukemia after allogeneic peripheral blood stem cell transplantation","volume":"92","author":"Cho","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.V124.21.960.960","article-title":"The Addition of Radiation Therapy to Initial Treatment for Extramedullary Acute Myeloid Leukemia Does Not Offer a Survival Benefit When Added to Chemotherapy","volume":"124","author":"Feller","year":"2014","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.leukres.2016.12.003","article-title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","volume":"53","author":"Lazzarotto","year":"2017","journal-title":"Leuk. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Wei","year":"2022","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Shatilova, A., Girshova, L., Zaytsev, D., Budaeva, I., Mirolyubova, Y., Ryzhkova, D., Grozov, R., Bogdanov, K., Nikulina, T., and Motorin, D. (2021). The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: Rare case report. BMC Womens Health, 21.","DOI":"10.1186\/s12905-021-01328-y"},{"key":"ref_101","first-page":"100286","article-title":"Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome\/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen","volume":"17","author":"Mandhan","year":"2022","journal-title":"Leuk. Res. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/10781552221110826","article-title":"Orbital myeloid sarcoma treated with low-dose venetoclax and a potent cytochrome P450 inhibitor","volume":"29","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3324\/haematol.2022.280798","article-title":"New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia","volume":"108","author":"Mohty","year":"2023","journal-title":"Haematologica"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(23)00464-6","article-title":"Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Erba","year":"2023","journal-title":"Lancet"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/bloodadvances.2022009411","article-title":"Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML","volume":"7","author":"Fenaux","year":"2023","journal-title":"Blood Adv."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/cncr.34459","article-title":"Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations","volume":"128","author":"Ball","year":"2022","journal-title":"Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-020-02855-4","article-title":"Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation","volume":"112","author":"Kida","year":"2020","journal-title":"Int. J. Hematol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000518356","article-title":"A Relapsing Meningeal Acute Myeloid Leukaemia FLT3-ITD+ Responding to Gilteritinib","volume":"66","author":"Perrone","year":"2021","journal-title":"Chemotherapy"},{"key":"ref_109","first-page":"100219","article-title":"Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Kumode","year":"2020","journal-title":"Leuk. Res. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000524878","article-title":"Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature","volume":"145","author":"Arrigo","year":"2022","journal-title":"Acta Haematol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11864-022-01032-5","article-title":"Central Nervous System Prophylaxis and Treatment in Acute Leukemias","volume":"23","author":"Wu","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11912-022-01220-4","article-title":"Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management","volume":"24","author":"Paul","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/cncr.34182","article-title":"A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia","volume":"128","author":"Chen","year":"2022","journal-title":"Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-021-04356-5","article-title":"Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement","volume":"89","author":"Condorelli","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Cheng, C.L., Li, C.C., Hou, H.A., Fang, W.Q., Chang, C.H., Lin, C.T., Tang, J.L., Chou, W.C., Chen, C.Y., and Yao, M. (2015). Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1376-9"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0002-9343(87)90756-X","article-title":"Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission","volume":"83","author":"Peterson","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ajh.24799","article-title":"Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia","volume":"92","author":"Jabbour","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.26253","article-title":"Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease","volume":"118","author":"Shihadeh","year":"2012","journal-title":"Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2005-10-4165","article-title":"Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation","volume":"108","author":"Schmid","year":"2006","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3324\/haematol.2009.013920","article-title":"Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia","volume":"95","author":"Craddock","year":"2010","journal-title":"Haematologica"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/10428194.2012.720375","article-title":"Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia","volume":"54","author":"Kogut","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1200\/JCO.2007.15.6315","article-title":"Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: A retrospective study from the SFGM-TC","volume":"26","author":"Chevallier","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2011.041418","article-title":"Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: A report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation","volume":"96","author":"Chevallier","year":"2011","journal-title":"Haematologica"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/leu.2012.156","article-title":"Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma","volume":"26","author":"Shimizu","year":"2012","journal-title":"Leukemia"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/bmt.2015.82","article-title":"Allogeneic hematopoietic cell transplant for AML: No impact of pre-transplant extramedullary disease on outcome","volume":"50","author":"Goyal","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.bbmt.2012.05.010","article-title":"Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: An easily overlooked but significant pattern of relapse","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa1601202","article-title":"Ipilimumab for Patients with Relapse after Allogeneic Transplantation","volume":"375","author":"Davids","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/20\/6154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:14:07Z","timestamp":1760112847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/20\/6154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":127,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["jcm13206154"],"URL":"https:\/\/doi.org\/10.3390\/jcm13206154","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}